Abstract
This review will summarize the role of integrase in HIV-1 infection, the mechanism of integrase inhibitors and resistance with an emphasis on raltegravir (RAL), the fi rst integrase inhibitor licensed to treat HIV-1 infection. ©Elsevier Editora Ltda.
Author supplied keywords
Cite
CITATION STYLE
APA
Hazuda, D. J. (2010). Resistance to inhibitors of the human immunodeficiency virus type 1 integration. Brazilian Journal of Infectious Diseases. Elsevier Editora Ltda. https://doi.org/10.1016/s1413-8670(10)70103-3
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free